Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Med-XMXRX Receivables Turnover is 9.21 as of Dec. 2022.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Med-X's Revenue for the
six
months ended in Dec. 2022 was $0.97 Mil. Med-X's average Accounts Receivable for the
six
months ended in Dec. 2022 was $0.11 Mil.
Hence, Med-X's Receivables Turnover for the
six
months ended in Dec. 2022 was 9.21.
Med-X (NAS:MXRX) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Med-X Receivables Turnover Related Terms
Med-X Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Med-X's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med-X Receivables Turnover Chart
Med-X Annual Data
Trend
Dec20
Dec21
Dec22
Receivables Turnover
6.85
11.22
39.43
Med-X Semi-Annual Data
Dec20
Jun21
Dec21
Jun22
Dec22
Receivables Turnover
0.00
3.26
17.86
10.07
9.21
MXRX vs : Receivables Turnover Comparison
For the Household & Personal Products subindustry, Med-X's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med-X Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Med-X's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Med-X's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med-X (MXRX) has a Receivables Turnover of 9.21 as of Dec. 2022. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Med-X and its competitors.
Is Med-X's Receivables Turnover too high?
Med-X's current Receivables Turnover is 9.21. The Consumer Packaged Goods industry median Receivables Turnover is 9.33. Med-X's value of 9.21 is 1.3% below this industry median.
How does Med-X's Receivables Turnover compare to ?
Med-X's Receivables Turnover of 9.21 can be compared against companies in the Consumer Packaged Goods industry. The industry median Receivables Turnover is 9.33. Med-X's value of 9.21 is 1.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.33, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med-X's current Receivables Turnover of 9.21 is 1.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Med-X and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med-X's current Receivables Turnover is 9.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med-X stock overvalued right now?
Med-X (MXRX) has a current Receivables Turnover of 9.21. The current Receivables Turnover is 9.21 and 1.3% below the Consumer Packaged Goods industry median of 9.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Med-X (MXRX), the current Receivables Turnover is 9.21 as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Med-X Inc is engaged in the business of product development, distribution, and marketing of products, which currently consist of Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products include natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent developed for multiple industries, including professional pest control, turf care, janitorial, hospitality, transportation, and agriculture. Thermal-Aid, Thermal-Aid Zoo, and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children, and animals. Nature-Cide. Malibu Brands has only one product available, an all-natural essential oil pain management cream.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MXRX has been successfully added to your 
